Search

everythinglearnresearchcommunity

for

Search:↓

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Some skin tumors may start from hair follicle stem cells.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

Some supplements and hormones can increase hair loss by raising DHT levels.

Sports supplements can cause skin problems and may contain harmful substances.

MSUD patients need careful monitoring of amino acids and zinc to prevent severe symptoms.

The treatment was ineffective in humans.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Targeted therapies promoting differentiation could help treat basal cell carcinoma by exhausting cancer stem cells.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Activating Notch signaling can kill basal cell carcinoma cells.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Targeting ornithine decarboxylase can help prevent skin cancer.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

p63 may influence skin cancer development and cell differentiation.

A man with nevus comedonicus syndrome had multiple skin issues, including basal cell carcinomas, which improved with treatment.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.